These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31092428)

  • 1. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
    Kim JY; Kim SH; Kim HS
    Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
    Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
    Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.
    Woo HY; DO SI; Kim SH; Song SY; Kim HS
    Anticancer Res; 2019 Oct; 39(10):5361-5367. PubMed ID: 31570430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
    Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
    J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
    Jung YY; Sung JY; Kim JY; Kim HS
    Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis.
    Wang P; Cao Y; Zhan D; Wang D; Wang B; Liu Y; Li G; He W; Wang H; Xu L
    Int J Med Sci; 2018; 15(13):1480-1485. PubMed ID: 30443169
    [No Abstract]   [Full Text] [Related]  

  • 7. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
    Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
    Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
    Sung HY; Han J; Ju W; Ahn JH
    Oncol Rep; 2016 Jul; 36(1):535-41. PubMed ID: 27220283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epigenetic Modifier 5-Aza-2-deoxycytidine Triggers the Expression of
    Dudzik P; Trojan SE; Ostrowska B; Zemanek G; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
    Anticancer Res; 2019 May; 39(5):2395-2403. PubMed ID: 31092432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
    Rattanapan Y; Korkiatsakul V; Kongruang A; Chareonsirisuthigul T; Rerkamnuaychoke B; Wongkularb A; Wilailak S
    Cancer Genet; 2018 Aug; 224-225():37-40. PubMed ID: 29778234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
    Qu PP; Shi Z; Li N
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma.
    Ni H; Zhou Z; Jiang B; Yuan X; Cao X; Huang G; Li Y
    Tumour Biol; 2017 Mar; 39(3):1010428317695025. PubMed ID: 28351314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.